Literature DB >> 33800291

Downregulation of Snail by DUSP1 Impairs Cell Migration and Invasion through the Inactivation of JNK and ERK and Is Useful as a Predictive Factor in the Prognosis of Prostate Cancer.

Desirée Martínez-Martínez1, María-Val Toledo Lobo2,3, Pablo Baquero4, Santiago Ropero4, Javier C Angulo5, Antonio Chiloeches4, Marina Lasa1.   

Abstract

Dual specificity phosphatase 1 (DUSP1) is crucial in prostate cancer (PC), since its expression is downregulated in advanced carcinomas. Here, we investigated DUSP1 effects on the expression of mesenchymal marker Snail, cell migration and invasion, analyzing the underlying mechanisms mediated by mitogen-activated protein kinases (MAPKs) inhibition. To this purpose, we used different PC cells overexpressing or lacking DUSP1 or incubated with MAPKs inhibitors. Moreover, we addressed the correlation of DUSP1 expression with Snail and activated MAPKs levels in samples from patients diagnosed with benign hyperplasia or prostate carcinoma, studying its implication in tumor prognosis and survival. We found that DUSP1 downregulates Snail expression and impairs migration and invasion in PC cells. Similar results were obtained following the inhibition of c-Jun N-terminal kinase (JNK) and extracellular-signal-regulated kinase (ERK). In clinical samples, we evidenced an inverse correlation between DUSP1 expression and Snail levels, which are further associated with JNK and ERK activation. Consequently, the pattern DUSP1high/activated JNKlow/activated ERKlow/Snaillow is associated with an overall extended survival of PC patients. In summary, the ratio between DUSP1 and Snail expression, with additional JNK and ERK activity measurement, may serve as a potential biomarker to predict the clinical outcome of PC patients. Furthermore, DUSP1 induction or inhibition of JNK and ERK pathways could be useful to treat PC.

Entities:  

Keywords:  DUSP1; MAPK; Snail; biomarkers; migration and invasion; patient survival; prostate cancer

Year:  2021        PMID: 33800291      PMCID: PMC7962644          DOI: 10.3390/cancers13051158

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  64 in total

1.  Snail is a repressor of RKIP transcription in metastatic prostate cancer cells.

Authors:  S Beach; H Tang; S Park; A S Dhillon; E T Keller; W Kolch; K C Yeung
Journal:  Oncogene       Date:  2007-10-22       Impact factor: 9.867

Review 2.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

3.  Snail1 is over-expressed in prostate cancer.

Authors:  Sara Heebøll; Michael Borre; Peter David Ottosen; Lars Dyrskjøt; Torben Falck Orntoft; Niels Tørring
Journal:  APMIS       Date:  2009-03       Impact factor: 3.205

Review 4.  Molecular mechanisms of epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Jian Xu; Rik Derynck
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

5.  GP78 Cooperates with Dual-Specificity Phosphatase 1 To Stimulate Epidermal Growth Factor Receptor-Mediated Extracellular Signal-Regulated Kinase Signaling.

Authors:  Dhong Hyo Kho; Mohammed Hafiz Uddin; Madhumita Chatterjee; Andreas Vogt; Avraham Raz; Gen Sheng Wu
Journal:  Mol Cell Biol       Date:  2019-05-14       Impact factor: 4.272

6.  Snail as a potential marker for predicting the recurrence of prostate cancer in patients at stage T2 after radical prostatectomy.

Authors:  Yu-Ching Wen; Wei-Yu Chen; Wei-Jiunn Lee; Shun-Fa Yang; Liang-Ming Lee; Ming-Hsien Chien
Journal:  Clin Chim Acta       Date:  2014-02-07       Impact factor: 3.786

7.  Juglone suppresses epithelial-mesenchymal transition in prostate cancer cells via the protein kinase B/glycogen synthase kinase-3β/Snail signaling pathway.

Authors:  Fang Fang; Shuang Chen; Jing Ma; Jiabo Cui; Qiang Li; Guixian Meng; Liguo Wang
Journal:  Oncol Lett       Date:  2018-06-04       Impact factor: 2.967

8.  Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression.

Authors:  Pin-Shern Chen; Yuan-Wei Shih; Hsiang-Ching Huang; Hsing-Wen Cheng
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

Review 9.  Paxillin: a crossroad in pathological cell migration.

Authors:  Ana María López-Colomé; Irene Lee-Rivera; Regina Benavides-Hidalgo; Edith López
Journal:  J Hematol Oncol       Date:  2017-02-18       Impact factor: 17.388

10.  JNK-dependent gene regulatory circuitry governs mesenchymal fate.

Authors:  Sanjeeb Kumar Sahu; Angela Garding; Neha Tiwari; Sudhir Thakurela; Joern Toedling; Susanne Gebhard; Felipe Ortega; Nikolai Schmarowski; Benedikt Berninger; Robert Nitsch; Marcus Schmidt; Vijay K Tiwari
Journal:  EMBO J       Date:  2015-07-08       Impact factor: 11.598

View more
  6 in total

1.  Advances in the Knowledge of the Molecular Pathogenesis of High-Prevalence Tumors and Its Relevance for Their Future Clinical Management.

Authors:  Marta Rodríguez; Ion Cristóbal
Journal:  Cancers (Basel)       Date:  2021-12-01       Impact factor: 6.639

2.  Involvement of parathyroid hormone-related peptide in the aggressive phenotype of colorectal cancer cells.

Authors:  María Belén Novoa Díaz; Pedro Matías Carriere; María Julia Martín; Natalia Calvo; Claudia Gentili
Journal:  World J Gastroenterol       Date:  2021-11-07       Impact factor: 5.742

Review 3.  Thyroid hormones act as modulators of inflammation through their nuclear receptors.

Authors:  Marina Lasa; Constanza Contreras-Jurado
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

4.  Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods.

Authors:  Zi-Qian Liang; Rong-Quan He; Jia-Yuan Luo; Zhi-Guang Huang; Jie Li; Lu-Yang Zhong; Jun-Hong Chen; Su-Ning Huang; Lin Shi; Kang-Lai Wei; Jiang-Hui Zeng; Jing-Jing Zeng; Gang Chen
Journal:  Pathol Oncol Res       Date:  2022-07-15       Impact factor: 2.874

5.  LPAR5 confers radioresistance to cancer cells associated with EMT activation via the ERK/Snail pathway.

Authors:  Xiao-Ya Sun; Hao-Zheng Li; Da-Fei Xie; Shan-Shan Gao; Xin Huang; Hua Guan; Chen-Jun Bai; Ping-Kun Zhou
Journal:  J Transl Med       Date:  2022-10-05       Impact factor: 8.440

6.  A Novel L-Phenylalanine Dipeptide Inhibits the Growth and Metastasis of Prostate Cancer Cells via Targeting DUSP1 and TNFSF9.

Authors:  Lanlan Li; Mingfei Yang; Jia Yu; Sha Cheng; Mashaal Ahmad; Caihong Wu; Xinwei Wan; Bixue Xu; Yaacov Ben-David; Heng Luo
Journal:  Int J Mol Sci       Date:  2022-09-18       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.